Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Asset disposition Inv. presentation Quarterly results Appointed director
|
ADIAL PHARMACEUTICALS, INC. (ADIL)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/21/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
11/14/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
08/12/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
05/13/2022 |
10-Q
| Quarterly Report for the period ended March 31, 2022 |
08/12/2021 |
10-Q
| Quarterly Report for the period ended June 30, 2021 |
05/17/2021 |
10-Q
| Quarterly Report for the period ended March 31, 2021 |
11/13/2020 |
10-Q
| Quarterly Report for the period ended September 30, 2020 |
08/13/2020 |
10-Q
| Quarterly Report for the period ended June 30, 2020 |
05/14/2020 |
10-Q
| Quarterly Report for the period ended March 31, 2020 |
11/14/2019 |
10-Q
| Quarterly Report for the period ended September 30, 2019 |
08/13/2019 |
10-Q
| Quarterly Report for the period ended June 30, 2019 |
05/13/2019 |
10-Q
| Quarterly Report for the period ended March 31, 2019 |
11/13/2018 |
10-Q
| Quarterly Report for the period ended September 30, 2018 |
09/07/2018 |
10-Q
| Quarterly Report for the period ended June 30, 2018 |
|
|